Genetics and mechanisms of disease in Rett syndrome

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 4, 2005, Pages 419-425

  Mari, Francesca ^a   Kilstrup Nielsen, Charlotte ^b   Cambi, Franca ^c   Speciale, Caterina ^a   Mencarelli, Maria Antonietta ^a   Renieri, Alessandra ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

CLINICAL FEATURE; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; RETT SYNDROME; REVIEW; X LINKED MENTAL RETARDATION;

EID: 33645090670     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.11.001     Document Type: Review

References (47)

1. E. Trevathan et. al. Diagnostic criteria for Rett syndrome Ann. Neurol. 23 1988 425-428
2. B. Hagberg Rett Syndrome - Clinical & Biological Aspects 1st edn 1993 MacKeith Press
3. C. De Bona et. al. Preserved speech variant is allelic of classic Rett syndrome Eur. J. Hum. Genet. 8 2000 325-330
4. A. Renieri et. al. Rett syndrome: The complex nature of a monogenic disease J. Mol. Med. 81 2003 346-354
5. I. Meloni et. al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males Am. J. Hum. Genet. 67 2000 982-985
6. E. Scala et. al. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms J. Med. Genet. 42 2005 103-107
7. F. Mari et. al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome Hum. Mol. Genet. 14 2005 1935-1946
8. X. Nan et. al. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin Cell 88 1997 471-481
9. P.L. Jones et. al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription Nat. Genet. 19 1998 187-191
10. X. Nan et. al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature 393 1998 386-389
11. F. Fuks et. al. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation J. Biol. Chem. 278 2003 4035-4040
12. K. Harikrishnan et. al. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing Nat. Genet. 37 2005 254-264
13. N.K. Kaludov et. al. MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery Nucleic Acids Res. 28 2000 1921-1928
14. S. Horike et. al. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome Nat. Genet. 37 2005 31-40
15. H. Ng et. al. MBD2 is a transcriptional repressor belonging to MeCP1 histone deacetylase complex Nat. Genet. 23 1999 5-6
16. M. D'Esposito et. al. Isolation, physical mapping, and Northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2 Mamm. Genome 7 1996 533-535
17. B. Mullaney et. al. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain Neuroscience 123 2004 939-949
18. S. Kriaucionus et. al. The major form of MeCP2 has a novel N-terminus generated by alternative splicing Nucleic Acids Res. 32 2004 1818-1823
19. G.N. Mnatzakanian et. al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome Nat. Genet. 36 2004 339-341
20. S. Luikenhuis et. al. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice Proc. Natl. Acad. Sci. U S A 101 2004 6033-6038
21. F. Mari et. al. Germline mosaicism in Rett syndrome identified by prenatal diagnosis Clin. Genet. 67 2004 258-260
22. M. Zappella et. al. Preserved speech variants of the Rett syndrome: molecular and clinical analysis Am. J. Med. Genet. 104 2001 14-22
23. R. Amir et. al. Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome J. Med. Genet. 42 2005 e15
24. M. Zappella et. al. Study of MECP2 gene in Rett syndrome variants and autistic girls Am. J. Med. Genet. (Neuropsychiatr. Genet.) 119B 2003 102-107
25. F. Ariani et. al. Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication Hum. Mutat. 24 2004 172-177
26. R. Samaco et. al. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders Hum. Mol. Genet. 13 2004 629-639
27. H. Van Esch et. al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males Am. J. Hum. Genet. 77 2005 442-453
28. J. Guy et. al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome Nat. Genet. 27 2001 322-326
29. R.Z. Chen et. al. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice Nat. Genet. 27 2001 327-331
30. C. Colantuoni et. al. Gene expression profiling in postmortem Rett syndrome brain: Differential gene expression and patient classification Neurobiol. Dis. 8 2001 847-865
31. J. Traynor et. al. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations BMC Med. Genet. 3 2002 12
32. M. Tudor et. al. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain Proc. Natl. Acad. Sci. 99 2002 15536-15541
33. K. Martinowich et. al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation Science 302 2003 890-893
34. W.G. Chen et. al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2 Science 302 2003 885-889
35. K. Makedonski et. al. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression Hum. Mol. Genet. 14 2005 1049-1058
36. U. Nuber et. al. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome Hum. Mol. Genet. 14 2005 2247-2256
37. C. Pescucci et. al. Is Rett syndrome a loss-of-imprinting disorder? Nat. Genet. 37 2005 10-11
38. A. Collins et. al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice Hum. Mol. Genet. 13 2004 2679-2689
39. F. Laccone et. al. Prospects of a protein therapy by means of PTDs-MeCP2 fusion protein for Rett syndrome Eur. J. Hum. Genet. 13 Suppl. 1 2005 61
40. L. Weaving et. al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation Am. J. Hum. Genet. 75 2004 1079-1093
41. J. Tao et. al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation Am. J. Hum. Genet. 75 2004 1149-1154
42. J. Evans et. al. Early onset seizures and Rett-like features associated with mutations in CDKL5 Eur. J. Hum. Genet. 13 2005 1113-1120
43. P. Huppke et. al. Mutation analysis of the HDAC 1, 2, 8 and CDKL5 genes in Rett syndrome patients without mutations in MECP2 Am. J. Med. Genet. A 137 2005 136-138
44. V.M. Kalscheuer et. al. Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation Am. J. Hum. Genet. 72 2003 1401-1411
45. L. Huopaniemi et. al. Characterization of two unusual RS1 gene deletions segregating in Danish retinoschisis families Hum. Mutat. 16 2000 307-314
46. L. Abuhatzira et. al. Splicing mutation associated with Rett syndrome and an experimental approach for genetic diagnosis Hum. Genet. 17 2005 1-8
47. C. Pescucci et. al. Chromosome 2 deletion encompassing the MEP2 gene in a patient with autism and Rett-like features Clin. Genet. 64 2003 497-501